First Time Loading...

PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 22.6 EUR -1.74%
Updated: May 6, 2024

Income Statement

Earnings Waterfall
PharmaSGP Holding SE

Revenue
89.3m EUR
Cost of Revenue
-8.9m EUR
Gross Profit
80.4m EUR
Operating Expenses
-60.6m EUR
Operating Income
19.7m EUR
Other Expenses
-6.6m EUR
Net Income
13.1m EUR

Income Statement
PharmaSGP Holding SE

Rotate your device to view
Income Statement
Currency: EUR
Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023
Revenue
Revenue
63
N/A
64
+3%
65
+1%
65
+1%
63
-3%
59
-7%
56
-5%
61
+9%
65
+7%
74
+13%
81
+10%
83
+3%
86
+3%
89
+4%
Gross Profit
Cost of Revenue
(6)
(5)
(6)
(6)
(6)
(6)
(6)
(6)
(6)
(8)
(9)
(9)
(9)
(9)
Gross Profit
57
N/A
59
+4%
59
+1%
60
+1%
57
-5%
53
-7%
50
-5%
55
+9%
59
+7%
66
+12%
72
+10%
74
+2%
77
+4%
80
+5%
Operating Income
Operating Expenses
(34)
(35)
(35)
(36)
(42)
(41)
(40)
(43)
(43)
(50)
(56)
(57)
(59)
(61)
Selling, General & Administrative
(30)
(11)
(18)
(19)
(35)
(11)
(5)
(5)
(36)
(5)
(5)
(5)
(44)
(56)
Depreciation & Amortization
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(4)
(6)
(8)
(9)
(9)
(9)
Other Operating Expenses
(4)
(24)
(16)
(16)
(7)
(28)
(35)
(37)
(4)
(39)
(43)
(43)
(5)
5
Operating Income
22
N/A
24
+5%
24
+4%
24
-2%
15
-39%
12
-21%
10
-10%
12
+12%
16
+37%
16
+1%
16
+2%
17
+1%
18
+7%
20
+11%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(2)
(2)
(2)
Non-Reccuring Items
0
(1)
(2)
(2)
(0)
0
0
0
(1)
0
0
0
(0)
0
Pre-Tax Income
22
N/A
23
+2%
23
-1%
22
-3%
14
-35%
11
-19%
10
-10%
11
+9%
14
+27%
15
+5%
15
0%
15
-1%
16
+8%
17
+10%
Net Income
Tax Provision
(6)
(6)
(6)
(6)
(4)
(3)
(3)
(3)
(4)
(4)
(4)
(4)
(4)
(4)
Income from Continuing Operations
17
17
17
16
11
9
8
8
11
11
11
11
12
13
Net Income (Common)
17
N/A
17
+2%
17
-1%
16
-3%
11
-35%
9
-19%
8
-10%
8
+9%
11
+27%
11
+5%
11
0%
11
-1%
12
+9%
13
+10%
EPS (Diluted)
1.39
N/A
1.42
+2%
1.41
-1%
1.36
-4%
0.89
-35%
0.71
-20%
0.64
-10%
0.7
+9%
0.89
+27%
0.93
+4%
0.93
N/A
0.92
-1%
1
+9%
1.09
+9%

See Also

Discover More